Payment for medical authors

Por Smyth, M J
Publicado em 1979

F.R.C.S. in the Specialties

Por Smyth, M. J.
Publicado em 1964

Molecular mechanisms of natural killer cell activation in response to cellular stress

Por Chan, C J, Smyth, M J, Martinet, L
Publicado em 2014

The in vitro and in vivo anti-tumour activity of N-AcMEL-(Fab')2 conjugates.

Por Smyth, M. J., Pietersz, G. A., McKenzie, I. F.
Publicado em 1987

Activation of human peripheral blood T lymphocytes by pharmacological induction of protein-tyrosine phosphorylation.

Por O'Shea, J J, McVicar, D W, Bailey, T L, Burns, C, Smyth, M J
Publicado em 1992

prICE: a downstream target for ceramide-induced apoptosis and for the inhibitory action of Bcl-2.

Por Smyth, M J, Perry, D K, Zhang, J, Poirier, G G, Hannun, Y A, Obeid, L M
Publicado em 1996

p53-dependent ceramide response to genotoxic stress.

Por Dbaibo, G S, Pushkareva, M Y, Rachid, R A, Alter, N, Smyth, M J, Obeid, L M, Hannun, Y A
Publicado em 1998

Contribution of humoral immune responses to the antitumor effects mediated by anthracyclines

Por Hannani, D, Locher, C, Yamazaki, T, Colin-Minard, V, Vetizou, M, Aymeric, L, Viaud, S, Sanchez, D, Smyth, M J, Bruhns, P, Kroemer, G, Zitvogel, L
Publicado em 2014

NK cell intrinsic regulation of MIP-1α by granzyme M

Por Baschuk, N, Wang, N, Watt, S V, Halse, H, House, C, Bird, P I, Strugnell, R, Trapani, J A, Smyth, M J, Andrews, D M
Publicado em 2014

The granzyme B-Serpinb9 axis controls the fate of lymphocytes after lysosomal stress

Por Bird, C H, Christensen, M E, Mangan, M S J, Prakash, M D, Sedelies, K A, Smyth, M J, Harper, I, Waterhouse, N J, Bird, P I
Publicado em 2014

Granzyme M has a critical role in providing innate immune protection in ulcerative colitis

Por Souza-Fonseca-Guimaraes, F, Krasnova, Y, Putoczki, T, Miles, K, MacDonald, K P, Town, L, Shi, W, Gobe, G C, McDade, L, Mielke, L A, Tye, H, Masters, S L, Belz, G T, Huntington, N D, Radford-Smith, G, Smyth, M J
Publicado no Cell Death Dis (2016)

Analysis of the apoptotic and therapeutic activities of histone deacetylase inhibitors by using a mouse model of B cell lymphoma

Por Lindemann, R. K., Newbold, A., Whitecross, K. F., Cluse, L. A., Frew, A. J., Ellis, L., Williams, S., Wiegmans, A. P., Dear, A. E., Scott, C. L., Pellegrini, M., Wei, A., Richon, V. M., Marks, Paul A., Lowe, S. W., Smyth, M. J., Johnstone, R. W.
Publicado em 2007

Predictors of responses to immune checkpoint blockade in advanced melanoma

Por Jacquelot, N., Roberti, M. P., Enot, D. P., Rusakiewicz, S., Ternès, N., Jegou, S., Woods, D. M., Sodré, A. L., Hansen, M., Meirow, Y., Sade-Feldman, M., Burra, A., Kwek, S. S., Flament, C., Messaoudene, M., Duong, C. P. M., Chen, L., Kwon, B. S., Anderson, A. C., Kuchroo, V. K., Weide, B., Aubin, F., Borg, C., Dalle, S., Beatrix, O., Ayyoub, M., Balme, B., Tomasic, G., Di Giacomo, A. M., Maio, M., Schadendorf, D., Melero, I., Dréno, B., Khammari, A., Dummer, R., Levesque, M., Koguchi, Y., Fong, L., Lotem, M., Baniyash, M., Schmidt, H., Svane, I. M., Kroemer, G., Marabelle, A., Michiels, S., Cavalcanti, A., Smyth, M. J., Weber, J. S., Eggermont, A. M., Zitvogel, L.
Publicado no Nat Commun (2017)